MAESTRELLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 9.599
EU - Europa 6.321
AS - Asia 4.045
SA - Sud America 706
Continente sconosciuto - Info sul continente non disponibili 224
AF - Africa 129
OC - Oceania 54
Totale 21.078
Nazione #
US - Stati Uniti d'America 9.449
RU - Federazione Russa 1.877
IT - Italia 1.792
SG - Singapore 1.108
CN - Cina 966
PL - Polonia 895
BR - Brasile 563
HK - Hong Kong 529
VN - Vietnam 451
IE - Irlanda 422
KR - Corea 330
SE - Svezia 330
DE - Germania 210
UA - Ucraina 205
IN - India 185
FR - Francia 163
FI - Finlandia 144
GB - Regno Unito 124
JO - Giordania 106
CA - Canada 82
BD - Bangladesh 75
ID - Indonesia 67
TR - Turchia 57
AU - Australia 53
AR - Argentina 46
ES - Italia 38
NL - Olanda 37
JP - Giappone 33
MX - Messico 30
EC - Ecuador 26
BE - Belgio 25
PK - Pakistan 25
IQ - Iraq 23
MA - Marocco 21
SC - Seychelles 21
CO - Colombia 19
PT - Portogallo 16
EG - Egitto 15
VE - Venezuela 13
CI - Costa d'Avorio 12
PE - Perù 12
DZ - Algeria 11
UZ - Uzbekistan 11
CL - Cile 10
PH - Filippine 10
SA - Arabia Saudita 10
ZA - Sudafrica 10
NG - Nigeria 9
BO - Bolivia 8
LT - Lituania 8
AZ - Azerbaigian 7
NP - Nepal 7
PY - Paraguay 7
TN - Tunisia 7
CH - Svizzera 6
IR - Iran 6
KE - Kenya 6
SV - El Salvador 6
AE - Emirati Arabi Uniti 5
BJ - Benin 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
MY - Malesia 5
TH - Thailandia 5
CZ - Repubblica Ceca 4
ET - Etiopia 4
KZ - Kazakistan 4
BB - Barbados 3
BG - Bulgaria 3
CR - Costa Rica 3
DK - Danimarca 3
DM - Dominica 3
HN - Honduras 3
KG - Kirghizistan 3
MZ - Mozambico 3
NO - Norvegia 3
OM - Oman 3
RO - Romania 3
GT - Guatemala 2
JM - Giamaica 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AT - Austria 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GR - Grecia 1
IL - Israele 1
Totale 20.842
Città #
Santa Clara 1.810
Ashburn 1.093
Warsaw 890
Fairfield 844
Singapore 789
Hong Kong 429
Dublin 419
San Jose 402
Chandler 399
Woodbridge 374
Seoul 327
Seattle 322
Houston 310
Jacksonville 306
Milan 306
Cambridge 302
Wilmington 255
Hefei 235
Ann Arbor 201
Florence 200
Beijing 188
Rome 184
Council Bluffs 179
Altamura 167
Ho Chi Minh City 167
Lawrence 152
The Dalles 123
Princeton 122
Los Angeles 121
Lauterbourg 108
Boston 99
Dallas 89
Boardman 88
Hanoi 88
Moscow 83
Buffalo 73
New York 61
Mumbai 57
São Paulo 54
Melbourne 52
San Diego 52
Naples 41
Helsinki 40
Jakarta 39
Orem 39
Munich 38
Shanghai 37
Medford 36
Kent 34
Paris 32
Columbus 30
Chicago 29
Turin 29
Tokyo 28
West Jordan 26
Clifton 25
Da Nang 25
Bologna 24
Brussels 24
Toronto 23
Auburn Hills 20
Guangzhou 19
Izmir 19
Rio de Janeiro 19
Verona 19
Figino 17
Genoa 17
Dong Ket 16
Haiphong 16
London 16
Palermo 16
Andover 15
Brooklyn 15
Catania 15
Miano 15
North Bergen 15
Norwalk 15
Atlanta 14
Barcelona 14
Bari 14
Bengaluru 14
Falls Church 14
Frankfurt Am Main 14
Mexico City 14
Chennai 13
Manchester 13
Modugno 13
Montreal 13
Abidjan 12
Belo Horizonte 12
Lappeenranta 12
Monza 12
Phoenix 12
Redondo Beach 12
Modena 11
Pescara 11
Turku 11
Cagliari 10
Denver 10
Giza 10
Totale 13.688
Nome #
Esercizi di ripasso 395
Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins 382
Solid state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-B-cyclodextrin ternary systems 339
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 336
Combined Approach of Cyclodextrin Complexation and Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide 301
Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide 293
Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus 281
Solid lipid nanoparticles as new strategy for oral delivery of nebivolol hydrochloride 243
Niosomal Formulation of a Lipoyl-Carnosine Derivative Targeting TRPA1 Channels in Brain 241
Comparison of the effect of chitosan and polyvinylpyrrolidone on dissolution properties and analgesic effect of naproxen 234
Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System 231
Comparative study of oxaprozin complexation with natural and chemically-modified cyclodextrins in solution and in the solid state 228
Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib 221
A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin 220
Comparative evaluation of polymeric and waxy microspheres for combined colon delivery of ascorbic acid and ketoprofen 217
β-sitosterol lipid nano carrier based on propolis wax and pomegranate seed oil: Effect of thermal processing, pH and ionic strength on stability and structure 215
Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamide, 213
Characterization and microbiological evaluation of chitosan-alginate microspheres for cefixime vaginal administration 210
Combined use of bile acids and aminoacids to improve permeation properties of acyclovir 209
A preliminary study for the development and optimization by experimental design of an in vitro method for prediction of drug buccal absorption 209
Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-ß-cyclodextrin and L-arginine aimed to improve the drug solubility 208
Advanced formulations for improving therapies with anti-inflammatory or anaesthetic drugs: A review 207
Novel Findings about Double-Loaded Curcuminin HPbcyclodextrin-in Liposomes: Effects on the Lipid Bilayer and Drug Release 207
Chitosan coated niosomes for nose-to-brain delivery of clonazepam: Formulation, stability and permeability studies 202
Development of a cyclodextrin-based mucoadhesive-thermo-sensitive in situ gel for clonazepam intranasal delivery 196
Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation 194
Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants 193
Comparative study on triclosan interactions in solution and in the solid state with natural and chemically modified cyclodextrins 192
Development and characterization of fast dissolving tablets of oxaprozin based on hybrid systems of the drug with cyclodextrins and nanoclays 192
Taste Masking of Dexketoprofen Trometamol Orally Disintegrating Granules by High-Shear Coating with Glyceryl Distearate 191
Development and characterization of naproxen-chitosan solid systems with improved dissolution properties 191
Tecnologia Farmaceutica 187
New docking CFF91 parameters specific for cyclodextrin inclusion complexes 186
120) Effect of cyclodextrin complexation on theophylline release from coated polymeric matrix tablets 186
Assessment of artificial membranes aimed for in vitro study of drug buccal permeation using experimental design 185
Cyclodextrin complexation as a fruitful strategy for improving the performance of nebivolol delivery from solid lipid nanoparticles 184
Analysis of triclosan complexes with b-ciclodextrin and its water-soluble polymeric derivative 183
Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. 183
Physical chemical characterization of binary systems of prilocaine hydrochloride with triacetyl-b-cyclodextrin 182
Development, characterization and in vivo evaluation of benzocaine-loaded liposomes 181
Phase solubility, 1H NMR and molecular modelling studies of bupivacaine hydrochloride complexation with different cyclodextrin derivates 178
Tablets of “Hydrochlorothiazide in Cyclodextrin in Nanoclay”: A New Nanohybrid System with Enhanced Dissolution Properties 177
Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: Effect of randomly methylated β-cyclodextrin 175
Response surface methodology in the optimization of chitosan-Ca pectinate bead formulations 175
Development of cyclodextrin hydrogels for vaginal delivery of dehydroepiandrosterone 174
Hybrid systems based on “drug – in cyclodextrin – in nanoclays” for improving oxaprozin dissolution properties 171
The influence of chitosan on cyclodextrin complexing and solubilizing abilities towards drugs 171
Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics 171
Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use 170
Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques 170
Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state. 170
Solid state characterization of glyburide-cyclodextrin co-ground products 168
Study of formulation variables influencing the drug release rate from matrix tablets by experimental design 167
Optimization of dissolution test precision for a ketoprofen oral extended-release product 167
Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations 167
Effect of preparation technique on the properties of liposomes encapsulating ketoprofen–cyclodextrin complexes aimed for transdermal delivery 166
Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques 166
Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique 164
Combined use of cyclodextrins and amino acids for the development of cefixime oral solutions for pediatric use 164
The role of solid state properties on the dissolution performance of flufenamic acid 163
Polymeric mucoadhesive tablets for topical or systemic buccal delivery of clonazepam: Effect of cyclodextrin complexation 163
Role of Cyclodextrins and Drug Solid State Properties on Flufenamic Acid Dissolution Performance from Tablets 163
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study 161
Development of mucoadhesive films for buccal administration of flufenamic acid: Effect of cyclodextrin complexation. 160
β-Sitosterol Loaded Nanostructured Lipid Carrier: Physical and Oxidative Stability, In Vitro Simulated Digestion and Hypocholesterolemic Activity 159
COMPARATIVE STUDY OF IBUPROXAM COMPLEXATION WITH AMORPHOUS ß-CYCLODEXTRIN DERIVATIVES IN SOLUTION AND IN THE SOLID STATE 157
Formulation and characterization of triclosan sub-micron emulsions and nanocapsules 156
Photostability studies on nicardipine-cyclodextrin complexes by capillary electrophoresis. 155
Differential Scanning calorimetry as an analytical tool in the study of drug-cyclodextrin interactions 155
Improvement of butamben anesthetic efficacy by the development of deformable liposomes bearing the drug as cyclodextrin complex 154
Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery 153
Preparation and characterisation of liposomes encapsulating ketoprofen–cyclodextrin complexes for transdermal drug delivery 153
Propolis wax nanostructured lipid carrier for delivery of β sitosterol: Effect of formulation variables on physicochemical properties 153
Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline 150
Evaluation of supercritical fluid technology as preparative technique of benzocaine–cyclodextrin complexes—Comparison with conventional methods 150
Dissolution and permeation properties of Naproxen from solid-state systems with chitosan 150
Physical chemical characterization of binary systems of metformin hydrochloride with triacetyl-β-cyclodextrin 149
Fast-dissolving tablets of glyburide based on ternary solid dispersions with PEG 6000 and surfactants 148
New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics 148
Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability 147
Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review 147
Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets 145
Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization 145
Sustained release matrix tablets of metformin hydrochloride in combination with triacetyl-ß-cyclodextrin 145
Development of Oral Tablets of Nebivolol with Improved Dissolution Properties, Based on Its Combinations with Cyclodextrins 144
Casein‐based nanocarriers for encapsulation of propolis extract: Design, fabrication, and characterization 143
Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery 143
Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers 143
Dual carbonic anhydrase ix/xii inhibitors and carbon monoxide releasing molecules modulate LPS-mediated inflammation in mouse macrophages 142
Development of fast-dissolving tablets of flurbiprofen- cyclodextrin complexes 141
Development and evaluation of an in vitro method for prediction of human drug absorption: II. Demonstration of the method suitability 141
Development of low methoxy amidated pectin-based mucoadhesive patches for buccal delivery of triclosan: Effect of cyclodextrin complexation 140
Optimization of glibenclamide tablet composition through the combined use of Differential Scanning Calorimetry and D-optimal mixture experimental design. 139
Physical-chemical characterization of binary and ternary systems of ketoprofen with cyclodextrins and phospholipids 139
Optimization of formulation variables of benzocaine liposomes using experimental design 137
Effects of cyclodextrins and chitosan on gliburide dissolution and permeability through intestinal epithelial cells (Caco 2) 132
Characterization of phisicochemical properties of naproxen systems with amorphous b-cyclodextrin-epichlorohydrin polymers 131
Principi di calcolo farmaceutico 128
Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-ß-cyclodextrin on drug anaesthetic efficacy 128
Microspheres for colonic delivery of ketoprofen-hydroxypropyl-ß-cyclodextrin complex 126
Totale 18.305
Categoria #
all - tutte 57.887
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.887


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022734 0 65 98 18 17 32 53 48 51 22 141 189
2022/20231.965 192 393 61 155 140 324 267 104 229 24 53 23
2023/2024811 35 82 127 38 48 64 49 177 18 67 50 56
2024/20255.229 191 549 388 746 1.590 580 116 306 205 142 239 177
2025/20266.910 528 1.008 629 565 707 231 676 372 687 355 224 928
2026/2027504 289 215 0 0 0 0 0 0 0 0 0 0
Totale 21.078